top of page

Pliant's CEO on targeting integrins to treat fibrotic diseases like IPF and liver disease

May 14, 2024
1 min read

Bernard Coulie gives a deep dive into Pliant's IPF program, including news released this morning relating to patient PET scans.

Recent Posts

Oxford based Infinitopes raised an additional $15.4M in a second closing of its seed round to bring the total raised to $35.1M. It will have clinical data on its cancer vaccine by the end of the year

Oxford based Infinitopes raised an additional $15.4M in a second closing of its seed round to bring the total raised to $35.1M. It will have clinical data on its cancer vaccine by the end of the year

Upstream Bio's CEO Rand Sutherland discusses today's severe asthma data for verekitug, a TSLP receptor antagonist

Upstream Bio's CEO Rand Sutherland discusses today's severe asthma data for verekitug, a TSLP receptor antagonist

SLAS 2026: Atinary showed BiotechTV the "Self Driving Lab" it has created in the Seaport that integrates machine learning into the experiment design and optimization process to accelerate science

SLAS 2026: Atinary showed BiotechTV the "Self Driving Lab" it has created in the Seaport that integrates machine learning into the experiment design and optimization process to accelerate science

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page